Steven Binder
Corporate Officer/Principal at MANNKIND CORPORATION
Net worth: 3 M $ as of 2024-03-30
Profile
Steven B.
Binder's career history includes several positions in finance and strategic development.
He is currently the Executive Vice President-Special Projects at MannKind Corp.
Prior to his current role, he held the position of Vice President-Finance at Bristol Myers Squibb Co. from 2012 to 2013.
From 2013 to 2016, he served as the Chief Financial Officer & Vice President at Stryker Corp.
Before that, he was the Vice President-Finance at Bristol-Myers Squibb Pharmaceuticals Ltd.
from 2008 to 2011.
Additionally, he held the position of Vice President-Strategic Development at Oncology Therapeutics Network Corp.
from 2001 to 2003 and Vice President-Finance at Bristol-Myers Squibb KK from 2003 to 2005.
Mr. Binder obtained his undergraduate degree from Muhlenberg College in 1984.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MANNKIND CORPORATION
0.20% | 2024-03-20 | 552,345 ( 0.20% ) | 3 M $ | 2024-03-30 |
Steven Binder active positions
| Companies | Position | Start |
|---|---|---|
| MANNKIND CORPORATION | Corporate Officer/Principal | 2024-04-21 |
Former positions of Steven Binder
| Companies | Position | End |
|---|---|---|
| STRYKER CORPORATION | Director of Finance/CFO | 2016-03-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2013-08-31 |
Bristol-Myers Squibb Pharmaceuticals Ltd.
 Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Corporate Officer/Principal | 2010-12-31 |
Bristol-Myers Squibb KK
 Bristol-Myers Squibb KK BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb KK develops, manufactures and markets biopharmaceutical products. The private company is based in Shinjuku-ku, Japan. | Corporate Officer/Principal | 2004-12-31 |
Oncology Therapeutics Network Corp.
 Oncology Therapeutics Network Corp. Medical DistributorsDistribution Services Oncology Therapeutics Network Corp. distributes pharmaceuticals to oncologists. It also provides support services. The company was founded in 1990 and is headquartered in South San Francisco, CA. | Director of Finance/CFO | 1999-12-31 |
Training of Steven Binder
| Muhlenberg College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| STRYKER CORPORATION | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
Bristol-Myers Squibb Pharmaceuticals Ltd.
Bristol-Myers Squibb Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Pharmaceuticals Ltd. manufactures pharmaceutical products. Its products are used for treatment of diseases like cancer, diabetes, arthritis, hepatitis, and psychiatric disorders. The company distributes products throughout the United Kingdom. Bristol-Myers Squibb Pharmaceuticals was founded in 1989 and is located in Uxbridge, UK. | Health Technology |
Oncology Therapeutics Network Corp.
Oncology Therapeutics Network Corp. Medical DistributorsDistribution Services Oncology Therapeutics Network Corp. distributes pharmaceuticals to oncologists. It also provides support services. The company was founded in 1990 and is headquartered in South San Francisco, CA. | Distribution Services |
Bristol-Myers Squibb KK
Bristol-Myers Squibb KK BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Bristol-Myers Squibb KK develops, manufactures and markets biopharmaceutical products. The private company is based in Shinjuku-ku, Japan. | Health Technology |
- Stock Market
- Insiders
- Steven Binder
